Jaume Capdevila

PD-1 Blockade in Anaplastic Thyroid Carcinoma

Jaume Capdevila, Lori J. Wirth, Thomas Ernst et al. · Journal of Clinical Oncology · 2020 · 355 citations · Full text

Medicine, Oncology, Surgery +13

Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial

Marcia S. Brose, Bruce Robinson, Steven I. Sherman et al. · The Lancet Oncology · 2021 · 243 citations

Medicine, Oncology, Pharmacology +12

Phase 3 Trial of Selpercatinib in Advanced <i>RET</i> -Mutant Medullary Thyroid Cancer

Julien Hadoux, Rossella Elisei, Marcia S. Brose et al. · New England Journal of Medicine · 2023 · 190 citations

Medicine, Oncology, Pharmacology +13

Sorafenib in metastatic thyroid cancer

Jaume Capdevila, L. Iglesias, Irene Halperín et al. · Endocrine Related Cancer · 2012 · 111 citations · Full text

Medicine, Oncology, Pharmacology +14

Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer

Bruce Robinson, Martin Schlumberger, Lori J. Wirth et al. · The Journal of Clinical Endocrinology & Metabolism · 2016 · 92 citations · Full text

Medicine, Oncology, Pharmacology +17